Shin Kashima, Koji Sawada, Kentaro Moriichi, & Mikihiro Fujiya. (2022). A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn's disease. SAGE Publishing.
Chicago Style (17th ed.) CitationShin Kashima, Koji Sawada, Kentaro Moriichi, and Mikihiro Fujiya. A Case Report of Drug-induced Liver Injury Due to the Infliximab Biosimilar CT-P13 on Switching from Original Infliximab in a Patient with Crohn's Disease. SAGE Publishing, 2022.
MLA (9th ed.) CitationShin Kashima, et al. A Case Report of Drug-induced Liver Injury Due to the Infliximab Biosimilar CT-P13 on Switching from Original Infliximab in a Patient with Crohn's Disease. SAGE Publishing, 2022.
Warning: These citations may not always be 100% accurate.